Searchable abstracts of presentations at key conferences in endocrinology

ea0020p35 | Adrenal | ECE2009

Synacten test in patients with adrenal incidentaloma

Ivovic Miomira , Stojanovic Milos , Tancic-Gajic Milina , Marina Ljiljana , Vujovic Svetlana , Drezgic Milka

Considering that adrenal tumors are frequent in patients with congenital adrenal hyperplasia (82% in homozygote and 45% in heterozygote), Synacten test was at first introduced as marker of congenital adrenal deficiency in patient with adrenal incidentaloma. Recent studies showed normal and exaggerated cortisol response in more than 50% of patient with nonhypersecretory adrenal incidentaloma and more than 70% of patients with adrenal incidentaloma and subclinical hypercorticism...

ea0016p43 | Adrenal | ECE2008

Insulin sensitivity calucated by HOMA, QUIQI and G/IR in patients with adrenal incidentaloma

Ivovic Miomira , Vujovic Svetlana , Stojanovic Milos , Tancic-Gajic Milina , Marina Ljiljana , Barac Marija , Drezgic Milka

Many studies have shown insulin resistance (IR) in majority of patients with adrenal incidentaloma. The euglycaemic hyperinsulinaemic glucose clamp technique is still considered as ‘golden standard’ for evaluation of insuline sensitivity. These methods are also complicated, labor-intensive procedure better for small research studies. Today, several surrogate indexes for insulin sensitivity were introduced such as: HOMA, QUIQI or G/IR. Some studies showed that QUIQI h...

ea0016p773 | Thyroid | ECE2008

Surprising: hyperlipidemia in subclinical hyperthyroidism!

Marina Ljiljana , Vujovic Svetlana , Ivovic Miomira , Tancic-Gajic Milina , Stojanovic Milos , Barac Marija , Drezgic Milka

Subclinical hyperthyroidism is a biochemical diagnosis defined with suppressed levels of TSH and normal levels of thyroid hormones. One of the main metabolic responses to thyroid hyperfunction is peripheral lipolysis and release of free fatty acids (FFA). The aim of this study was to compare levels of cholesterol, LDL, HDL and triglycerides in persons with subclinical hyperthyroidism to age and BMI matched euthyroid healthy control. We evaluated 45 persons in two groups: 1st g...

ea0016p787 | Thyroid | ECE2008

Should we look for metabolic syndrome (MSy) in subclinical hypothyroidism?

Drezgic Milka , Marina Ljiljana , Ivovic Miomira , Tancic-Gajic Milina , Stojanovic Milos , Barac Marija , Vujovic Svetlana

Subclinical hypothyroidism is a biochemical diagnosis defined with elevated levels of TSH and normal levels of thyroid hormones. The most common abnormality linked to this condition is hypercholesterolemia. The aim of this study was to search for MSy among the persons with subclinical hypothyroidism which was already proven to have hypercholesterolemia when compared to healthy control. MSy was identified in those with elevated triglycerides (Tgc), reduced HDL and elevated fast...

ea0014p106 | (1) | ECE2007

Characteristics of metabolic syndrome in patients with adrenal incidentaloma

Ivovic Miomira , Vujovic Svetlana , Stojanovic Milos , Tancic-Gajic Milina , Marina Ljiljana , Barac Marija , Drezgic Milka

Several studies show that characteristics of metabolic syndrome are often seen in patients with adrenal incidentaloma. The aim of our study was to evaluate metabolic factors in these patients. 208 patients (148 female and 60 male, age 55.08±11.02 y’s and BMI 27.91±4.6 kg/m2) were admitted and biochemical, endocrine testing were performed. Lipid status: cholesterol 5.77±1.26 mmol/L, triglyceride 1.92±0.98 mmol/L. 113(55%) patients were hypert...

ea0014p209 | (1) | ECE2007

Influence of gaining weight on metabolic syndrome in the menopause

Simoncig-Netjasov Aleksandra , Vujovic Svetlana , Stojanovic Milos , Ivovic Miomira , Tancic Milina , Drezgic Milka

Metabolic syndrome (MS) represents a prominent risk factor for cardiovascular disease. Parameters of MS were compared between obese women and controls. I: 50 women (31.92±5.83 kg/m2; 54.4±3.64 y’s); Controls: 37 women (23.50±2.13 kg/m2; 53.92±3.95 y’s). Weight, height, waist and hips circumference, sagital abdominal diameter (SAD) and blood pressure (BP) were measured. Blood was taken at 8 am for: fasting glucose, triglycerid...

ea0014p644 | (1) | ECE2007

Atherogenic indexes in women with premature ovarian failure-POF

Marina Ljiljana , Vujovic Svetlana , Ivovic Miomira , Stojanovic Milos , Tancic-Gajic Milina , Barac Marija , Drezgic Milka

POF is a disease of unclear origin affecting women under age 40. They are at high risk of cardiovascular diseases (CVD).The objective of this study was to compare the lipid status and atherogenic indexes - total cholesterol/high density lipoprotein (TC/HDL) and low density lipoprotein/HDL (LDL/HDL) - of women with POF with healthy women of the same age and the same BMI.We evaluated 54 women in two groups. 1st group: 31 women with P...

ea0014p649 | (1) | ECE2007

Insulin levels and lipid profile in lean women with polycystic ovary syndrome

Stojkovic Mirjana , Zarkovic Milos , Ciric Jasmina , Beleslin Biljana , Savic Slavica , Marina Djordje , Trbojevic Bozo , Drezgic Milka

Background: Women with polycystic ovary syndrome (PCOS) appear at increased cardiovascular risk due in part to a dyslipidemia characterized by increased plasma triglyceride and reduced high density lipoprotein (HDL) cholesterol levels. Insulin resistance is one of the features of PCOS and potentially affect lipid metabolism.Objectives: The aim of this study was to compare basal insulin levels and lipid profile in lean women with PCOS with weight matched ...

ea0011p341 | Diabetes, metabolism and cardiovascular | ECE2006

Lipid profile in normal weight and obese women with polycystic ovary syndrome

Stojkovic M , Zarkovic M , Ciric J , Beleslin B , Savic S , Drezgic M , Trbojevic B

Background: Women with polycystic ovary syndrome (PCOS) appear at increased cardiovascular risk due in part to a dyslipidemia characterized by increased plasma triglyceride and reduced high density lipoprotein (HDL) cholesterol levels. Obesity, insulin resistance and hyperandrogenemia are features of PCOS and potentially affect lipid metabolism. On the other hand, obesity has an important influence on the lipid metabolism.Objectives: The aim of this stud...

ea0011p505 | Endocrine tumours and neoplasia | ECE2006

Chromogranin-A in adrenal incidentalomas – marker for tumour secretion

Ivovic M , Penezic Z , Vujovic S , Marina Lj , Stojanovic M , Drezgic M

Adrenal incidentalomas are incidentally discovered adrenal tumors by imaging methods without any prior suspicions of adrenal disease. Most of these tumors are functionally inactive but thorough investigations can reveal discrete hormone excess. Chromogranin A(CgA) is expressed in neuroendocrine cells throughout the body, including large and small intestine, adrenal medulla and pancreatic islets. It is a marker for carcinoid tumors, paragangliomas, and other neuroendocrine tumo...